Tech Company Financing Transactions
Erbi Biosystems Funding Round
On 1/6/2022, Erbi Biosystems raised $4 million in funding from private investors.
Transaction Overview
Company Name
Announced On
1/6/2022
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This latest financing will enable the company to expand operations to meet the growing demand for its Breez perfusion bioreactor product and develop extensions to enhance cell therapy applications.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
325 New Boston St. 6
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Undisclosed
Website
Email Address
Overview
Through microfluidic technology and integration, we at Erbi Biosystems have miniaturized large scale bioreactors to the milliliter scale. This technology enables control and parallelization, as well as greatly reducing the labor and space required by systems with traditional culturing systems.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Chiu
VP - Product Management
Kathie Schneider
Browse more venture capital transactions:
Prev: 1/6/2022: DNA Script venture capital transaction
Next: 1/6/2022: Exotel venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC transactions on this site are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs